IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $223,000 | -12.9% | 3,697 | -13.4% | 0.01% | -16.7% |
| Q3 2019 | $256,000 | -6.9% | 4,269 | -0.4% | 0.01% | -7.7% |
| Q2 2019 | $275,000 | -20.3% | 4,286 | +0.9% | 0.01% | -27.8% |
| Q1 2019 | $345,000 | +46.2% | 4,247 | -2.8% | 0.02% | +20.0% |
| Q4 2018 | $236,000 | -0.8% | 4,371 | -5.1% | 0.02% | +36.4% |
| Q3 2018 | $238,000 | -15.9% | 4,607 | -18.0% | 0.01% | +22.2% |
| Q4 2017 | $283,000 | -2.1% | 5,618 | -1.3% | 0.01% | -10.0% |
| Q3 2017 | $289,000 | +1.0% | 5,691 | +1.4% | 0.01% | 0.0% |
| Q2 2017 | $286,000 | +31.2% | 5,614 | +3.4% | 0.01% | +42.9% |
| Q1 2017 | $218,000 | +6.9% | 5,427 | +27.3% | 0.01% | -12.5% |
| Q4 2016 | $204,000 | – | 4,264 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |